中国与美国药典细菌内毒素检查法应用指导原则的比较和解读

doi:10.19803/j.1672-8629.20211190

中国药物警戒 ›› 2023, Vol. 20 ›› Issue (3): 317-320.
DOI: 10.19803/j.1672-8629.20211190

中国与美国药典细菌内毒素检查法应用指导原则的比较和解读

裴宇盛, 陈晨, 蔡彤, 赵小燕, 高华^*

中国食品药品检定研究院,北京 102629

收稿日期:2022-01-26 出版日期:2023-03-15 发布日期:2023-03-17
通讯作者: ^* 高华,女,博士,研究员,药品质量控制。E-mail: huag55@163.com
作者简介:裴宇盛,男,硕士,副研究员,药品质量控制。
基金资助:
国家重点研发计划（2019YFC1200704）

Comparison and interpretation of guidelines for the application of bacterial endotoxin tests in Chinese and American Pharmacopoeia

PEI Yusheng, CHEN Chen, CAI Tong, ZHAO Xiaoyan, GAO Hua^*

National Institutes for Food and Drug Control, Beijing 102629, China

Received:2022-01-26 Online:2023-03-15 Published:2023-03-17

摘要/Abstract

摘要： 目的为国内细菌内毒素检测、研究和药物警戒工作提供参考。方法参考《美国药典》1085细菌内毒素检查法应用指导原则和《中国药典》 9251细菌内毒素检查法应用指导原则,对中国与美国内毒素标准物质管理、质量管理的异同及指导原则中容易误读的要点等相关内容进行介绍和解读。结果中国与美国细菌内毒素检查法应用指导原则均在2020年被首次收载,在背景、检测、工作标准品标定、质量管理、限度计算、替代方法等方面给予了详细指导和论述。结论中国与美国内毒素检查法应用指导原则作为细菌内毒素检测领域的权威指导原则,为内毒素实验室检测人员及《中国药典》修订提供帮助与启示,并将在实践中不断调整和完善。

关键词: 细菌内毒素, 中国药典, 美国药典, 解读

Abstract: Objective To provide reference for the detection, research and pharmacovigilance related to bacterial endotoxin in China. Methods USP 1085 and Chinese Pharmacopoeia 9251 were studied, and the similarities and differences in endotoxin reference material management, quality management and sections prone to misinterpretation in the guidelines were introduced and interpreted. Results USP 1085 and Chinese Pharmacopoeia 9251 were included in 2020 for the first time. Practitioners were given detailed guidance and descriptions on the background, testing, working standard calibration, quality management, limit calculation, and alternative methods. Conclusion USP 1085 and Chinese Pharmacopoeia 9251, as an authoritative guideline for bacterial endotoxin detection, is quite helpful for personnel engaged in endotoxin testing and for revision of Chinese Pharmacopoeia. It will be constantly revised and improved in the process of practice.

Key words: bacterial endotoxin detection, Chinese Pharmacopoeia, United States Pharmacopoeia, interpretation

中图分类号:

R926

裴宇盛, 陈晨, 蔡彤, 赵小燕, 高华. 中国与美国药典细菌内毒素检查法应用指导原则的比较和解读[J]. 中国药物警戒, 2023, 20(3): 317-320.

PEI Yusheng, CHEN Chen, CAI Tong, ZHAO Xiaoyan, GAO Hua. Comparison and interpretation of guidelines for the application of bacterial endotoxin tests in Chinese and American Pharmacopoeia[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 317-320.

参考文献

[1] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China Vol IV(中华人民共和国药典四部)[M]. Beijing: China Medical Science Press, 2020: 19.
[2] The United States Pharmacopeial Convention. U.S.Pharmacopeia 43/ National Formulary 38[M]. Baltimore: United Book Press, 2020.
[3] POOLE S, DAWSON P, GAINES D.Second international standard for endotoxins: calibration in an international collaborative study[J]. Journal of Endotoxin Research, 1997, 4(3): 221-231.
[4] ELLIS TN, LEIMAN SA, KUEHN MJ.Naturally produced outer membrane vesicles from Peudomonas aeruginosa elicit a potent innate immune 1212 response via combined sensing of both lipopolysaccharide and protein components[J]. Infection and Immunity, 2010, 78(9): 3822-3831.
[5] SCHWECHHEIMER C, KUEHN MJ.Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions[J]. Nature Reviews Microbiology, 2015, 13(10): 605-619.
[6] SHEN CY, WU TT, LIU W, et al.Post-marketing surveillance and evaluation of Chinese drugs in the new era[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(10): 649-675.
[7] YUAN L, GAO Y, LU CF.Preliminary thinking on the establishment of pharmacovigilance system in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(11): 749-752.
[8] BROGDEN KA, PHILLIPS M.The ultrastructural morphology of endotoxins and lipopolysaccharides[J]. Electron Microscopy Reviews, ????, ?: ???-???.
[9] PEI YS, CAI T, ZHANG GL, et al.Application of WHO GPCL quality management concept in laboratories for bacterial endotoxin detection[J]. Chinese Pharmaceutical Affairs(中国药事), 2013, 27(7): 693-696.
[10] PEI YS, CAI T, ZHANG GL, et al.Solutions to treatment for out of specification of bacterial endotoxin test[J]. Science & Technology Reviews(科技导报), 2017, 35(10): 71-75.
[11] PEI YS, CAI T, CHEN C, et al.Study on the applicability of recombinant factor c method for detection of bacterial endotoxin[J]. China Pharmaceuticals(中国药业), 2019, 28(7), 19-22.
[12] PEI YS, CAI T, CHEN C, et al.Methodological study on the detection of bacterial endotoxin in fosaprepitant dimeglumine by recombinant factor C[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学杂志), 2019, 36(1), 1-4.
[13] PEI YS, CAI T, CHEN C, et al.Validation of a determination method for recombinant factor C of bacterial endotoxin[J]. Chinese Journal of Biologicals(中国生物制品学杂志), 2020, 33(1): 76-79.
[14] PEI YS, CAI T, CHEN C, et al.Study on the application of supplementary methods of bacterial endotoxin test in chinese pharmacopoe[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学杂志) , 2022, 39(6): 822-826.

中国与美国药典细菌内毒素检查法应用指导原则的比较和解读

Comparison and interpretation of guidelines for the application of bacterial endotoxin tests in Chinese and American Pharmacopoeia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	张雨琪, 徐昕怡, 朱兰, 朱彦. 药品剂型标准术语的比较研究[J]. 中国药物警戒, 2023, 20(8): 904-910.
[2]	郝钢, 韩峰, 周刚, 武星, 颜皓, 李旭扬, 候海玲, 宁霄, 崔黎. 注射用腺苷钴胺细菌内毒素检查方法学研究[J]. 中国药物警戒, 2023, 20(12): 1351-1356.
[3]	裴宇盛, 陈晨, 宁霄, 蔡彤. 首批单核细胞活化反应检查法专用细菌内毒素国家标准品的建立与应用[J]. 中国药物警戒, 2023, 20(11): 1217-1220.
[4]	周修森. 盐酸艾司洛尔注射液细菌内毒素检查法的实验研究[J]. 中国药物警戒, 2011, 8(4): 197-198.